Stock Events

Stock Events

CollPlant Biotechnologies 

$3.68
10
+$3.34+978.93% 19:54 Today

Statistics

Day High
3.9
Day Low
3.3
52W High
3.54
52W Low
0.2728
Volume
682
Avg. Volume
-
Mkt Cap
69.61M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Jul 8
$0.80
Jun 6
$0.10
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

2DecExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
Next
-0.33
-0.17
-0.01
0.16
Expected EPS
-0.0526
Actual EPS
N/A

Financials

-484.56%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
2.37MRevenue
-11.49MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CLGN. It's not an investment recommendation.
Amazon
3
AMZN
NVIDIA
3
NVDA
Coca-Cola
3
KO
NIO
3
NIO

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Precigen
PGEN
Mkt Cap2.49B
Precigen operates in the synthetic biology field, focusing on gene and cell therapies that compete with CollPlant's regenerative medicine products.
Organogenesis
ORGO
Mkt Cap223.89M
Organogenesis offers regenerative medicine products for wound care and surgical biologics, directly competing with CollPlant's tissue repair products.
Integra Lifesciences
IART
Mkt Cap1.31B
Integra LifeSciences produces regenerative tissue technologies and surgical implants, competing in the same space as CollPlant's bioprinting and regenerative medicine.
Vericel
VCEL
Mkt Cap2.1B
Vericel specializes in autologous cell therapies for markets that include sports medicine and severe burns, competing with CollPlant's regenerative medicine solutions.
Mimedx Group
MDXG
Mkt Cap655.92M
MiMedx Group specializes in placental biologics for regenerative purposes, directly competing with CollPlant's biosynthetic products and technologies.
Sanara MedTech
SMTI
Mkt Cap317.63M
Sanara MedTech offers products in wound and skincare, which competes with CollPlant's regenerative medicine and tissue repair technologies.
Regeneron Pharmaceuticals
REGN
Mkt Cap81.77B
Regeneron Pharmaceuticals, known for its regenerative medicine and biopharmaceuticals, competes in the broader market of biotechnologies and medical solutions that CollPlant is also targeting.

About

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives majority revenue, Canada, Europe and Other, and Israel.
Show more...
CEO
Yehiel Tal
Employees
39
Country
Israel
ISIN
IL0004960188
WKN
000A1CY27

Listings

MU
DE
CPTA.MU
F
DE
CPT.F
BOATS
BOATS
CLGN.BOATS
XNAS
US
CLGN

0 Comments

Share your thoughts

FAQ

What is CollPlant Biotechnologies stock price today?▼
The current price of CLGN is $3.68 USD — it has increased by +978.93% in the past 24 hours. Watch CollPlant Biotechnologies stock price performance more closely on the chart.
What is CollPlant Biotechnologies stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange CollPlant Biotechnologies stocks are traded under the ticker CLGN.
Is CollPlant Biotechnologies stock price growing?▼
CLGN stock has risen by +852.51% compared to the previous week, the month change is a +1,088.98% rise, over the last year CollPlant Biotechnologies has showed a +30.75% increase.
What is CollPlant Biotechnologies market cap?▼
Today CollPlant Biotechnologies has the market capitalization of 69.61M
When is the next CollPlant Biotechnologies earnings date?▼
CollPlant Biotechnologies is going to release the next earnings report on December 02, 2026.
What is CollPlant Biotechnologies revenue for the last year?▼
CollPlant Biotechnologies revenue for the last year amounts to 2.37M USD.
What is CollPlant Biotechnologies net income for the last year?▼
CLGN net income for the last year is -11.49M USD.
Does CollPlant Biotechnologies pay dividends?▼
Yes, CLGN dividends are paid annual. The last dividend per share was 0.8 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does CollPlant Biotechnologies have?▼
As of September 04, 2026, the company has 39 employees.
In which sector is CollPlant Biotechnologies located?▼
CollPlant Biotechnologies operates in the Health & Wellness sector.
When did CollPlant Biotechnologies complete a stock split?▼
The last stock split for CollPlant Biotechnologies was on November 20, 2016 with a ratio of 1:3.
Where is CollPlant Biotechnologies headquartered?▼
CollPlant Biotechnologies is headquartered in Rehovot, Israel.